 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 June 2002 | Volume 136 Issue 11 | Pages 834-844
Recent years have witnessed a rapidly growing crisis in antimicrobial resistance, especially among microorganisms that cause nosocomial infection. To better understand common risk factors among multiresistant organisms, this review explores risk factors for nosocomial infection with methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, Clostridium difficile, extended-spectrum ß-lactamase-producing gram-negative bacilli, and Candida. This review comprises data from 74 published studies; 53 (71%) were retrospective studies and addressed few risk factors or did not quantify risk. The analysis shows impressive commonality of risk factors across these diverse multiresistant organisms: advanced age; underlying diseases and severity of illness; inter-institutional transfer of the patient, especially from a nursing home; prolonged hospitalization; gastrointestinal surgery or transplantation; exposure to invasive devices of all types, especially central venous catheters; and exposure to antimicrobial drugs, especially cephalosporins.
More restricted use of antibiotics, especially cephalosporins, and strategies to prevent medical device-related infection and cross-infection in the hospital would yield benefit with all types of resistant organisms. Preemptive isolation of all patients with risk factors for infection by resistant organisms would very likely reduce secondary spread within the hospital. Conversely, programs that focus on only one organism or one antimicrobial drug are unlikely to succeed. Prospective studies of sufficient size that address all potential risk factors, especially individual anti-infective agents, and that use matched controls who are shown by surveillance cultures to be free of colonization by resistant organisms would enhance understanding of the epidemiology of antimicrobial resistance in institutions and guide efforts to develop more effective strategies for prevention.
Author and Article Information
From University of Wisconsin Hospital and Clinics, Madison, Wisconsin.
Presented in part at the Fourth International Decennial Conference on Nosocomial and Health-Care Associated Infections on 5 March 2000 in Atlanta, Georgia, and published in abstract form (Safdar N, Maki DG. An analysis of risk factors for nosocomial infection with antimicrobial-resistant pathogens: MRSA, VRE, C. difficile, ESBL-positive GNB, and Candida [Abstract]. Infect Control Hosp Epidemiol. 2000; 21:132).
Grant Support: In part by a gift for research in infection control from the Oscar Rennebohm Foundation of Madison, Wisconsin.
Requests for Single Reprints: Dennis G. Maki, MD, Department of Medicine, H4/572 University of Wisconsin Hospital and Clinics, 600 Highland Avenue, Madison, WI 53792.
Current Author Addresses: Drs. Safdar and Maki: Department of Medicine, University of Wisconsin Hospital and Clinics, 600 Highland Avenue, H4/572, Madison, WI, 53792. REVIEW
The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  N. Vernaz, H. Sax, D. Pittet, P. Bonnabry, J. Schrenzel, and S. Harbarth Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile J. Antimicrob. Chemother., May 8, 2008; (2008) dkn199v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Nathwani, M. Morgan, R. G. Masterton, M. Dryden, B. D. Cookson, G. French, D. Lewis, and on behalf of the British Society for Antimicrobial Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community J. Antimicrob. Chemother., May 1, 2008; 61(5): 976 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Paule, D. M. Hacek, B. Kufner, K. Truchon, R. B. Thomson Jr., K. L. Kaul, A. Robicsek, and L. R. Peterson Performance of the BD GeneOhm Methicillin-Resistant Staphylococcus aureus Test before and during High-Volume Clinical Use J. Clin. Microbiol., September 1, 2007; 45(9): 2993 - 2998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. H. F. Goessens, J. W. Mouton, M. T. ten Kate, A. J. Bijl, A. Ott, and I. A. J. M. Bakker-Woudenberg Role of ceftazidime dose regimen on the selection of resistant Enterobacter cloacae in the intestinal flora of rats treated for an experimental pulmonary infection J. Antimicrob. Chemother., March 1, 2007; 59(3): 507 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hallin, O. Denis, A. Deplano, R. De Mendonca, R. De Ryck, S. Rottiers, and M. J. Struelens Genetic relatedness between methicillin-susceptible and methicillin-resistant Staphylococcus aureus: results of a national survey J. Antimicrob. Chemother., March 1, 2007; 59(3): 465 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. D. Rosenthal, D. G. Maki, R. Salomao, C. A. Moreno, Y. Mehta, F. Higuera, L. E. Cuellar, O. A. Arikan, R. Abouqal, H. Leblebicioglu, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med, October 17, 2006; 145(8): 582 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Furukawa, S. L. Kuchma, and G. A. O'Toole Keeping Their Options Open: Acute versus Persistent Infections J. Bacteriol., February 15, 2006; 188(4): 1211 - 1217. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dial, J. A. C. Delaney, A. N. Barkun, and S. Suissa Use of Gastric Acid-Suppressive Agents and the Risk of Community-Acquired Clostridium difficile-Associated Disease JAMA, December 21, 2005; 294(23): 2989 - 2995. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Barlow and D Nathwani Is antibiotic resistance a problem? A practical guide for hospital clinicians Postgrad. Med. J., November 1, 2005; 81(961): 680 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. MacDougall and R. E. Polk Antimicrobial Stewardship Programs in Health Care Systems Clin. Microbiol. Rev., October 1, 2005; 18(4): 638 - 656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Paterson and R. A. Bonomo Extended-Spectrum {beta}-Lactamases: a Clinical Update Clin. Microbiol. Rev., October 1, 2005; 18(4): 657 - 686. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. DiNubile, J. W. Chow, V. Satishchandran, A. Polis, M. R. Motyl, M. A. Abramson, and H. Teppler Acquisition of Resistant Bowel Flora during a Double-Blind Randomized Clinical Trial of Ertapenem versus Piperacillin-Tazobactam Therapy for Intraabdominal Infections Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3217 - 3221. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Graffunder, K. E. Preston, A. M. Evans, and R. A. Venezia Risk factors associated with extended-spectrum {beta}-lactamase-producing organisms at a tertiary care hospital J. Antimicrob. Chemother., July 1, 2005; 56(1): 139 - 145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Jacoby and L. S. Munoz-Price The New {beta}-Lactamases N. Engl. J. Med., January 27, 2005; 352(4): 380 - 391. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Schaier, C. Wendt, M. Zeier, and E. Ritz Clostridium difficile diarrhoea in the immunosuppressed patient--update on prevention and management Nephrol. Dial. Transplant., October 1, 2004; 19(10): 2432 - 2436. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Rothfork, G. S. Timmins, M. N. Harris, X. Chen, A. J. Lusis, M. Otto, A. L. Cheung, and H. D. Gresham Inactivation of a bacterial virulence pheromone by phagocyte-derived oxidants: New role for the NADPH oxidase in host defense PNAS, September 21, 2004; 101(38): 13867 - 13872. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dial, K. Alrasadi, C. Manoukian, A. Huang, and D. Menzies Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies Can. Med. Assoc. J., July 6, 2004; 171(1): 33 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Oprea, N. Zaidi, S. M. Donabedian, M. Balasubramaniam, E. Hershberger, and M. J. Zervos Molecular and clinical epidemiology of vancomycin-resistant Enterococcus faecalis J. Antimicrob. Chemother., April 1, 2004; 53(4): 626 - 630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Brown and B. B Freeman III Combining Quinupristin/Dalfopristin with Other Agents for Resistant Infections Ann. Pharmacother., April 1, 2004; 38(4): 677 - 685. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Tacconelli, L. Venkataraman, P. C. De Girolami, and E. M. C. D'Agata Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: distinguishing between community-acquired versus healthcare-associated strains J. Antimicrob. Chemother., March 1, 2004; 53(3): 474 - 479. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Rothfork, S. Dessus-Babus, W. J. B. Van Wamel, A. L. Cheung, and H. D. Gresham Fibrinogen Depletion Attenuates Staphyloccocus aureus Infection by Preventing Density-Dependent Virulence Gene Up-Regulation J. Immunol., November 15, 2003; 171(10): 5389 - 5395. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Horvat, N. E. Klutman, M. K. Lacy, D. Grauer, and M. Wilson Effect of Duplicate Isolates of Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus on Antibiogram Data J. Clin. Microbiol., October 1, 2003; 41(10): 4611 - 4616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. M. Zetola Health Care-Associated Bloodstream Infections Ann Intern Med, August 5, 2003; 139(3): 232 - 232. [Full Text] [PDF]
|
|
|
|
|
|
N. Safdar, L. Narans, B. Gordon, and D. G. Maki Comparison of Culture Screening Methods for Detection of Nasal Carriage of Methicillin-Resistant Staphylococcus aureus: a Prospective Study Comparing 32 Methods J. Clin. Microbiol., July 1, 2003; 41(7): 3163 - 3166. [Abstract] [Full Text] [PDF]
|
|
Article
